Expert Comparison from Regulated UK Pharmacy
Compare Mounjaro and Wegovy: GPhC Registered Pharmacy Advantage
When you compare Mounjaro and Wegovy through EverydayMeds, you're accessing both treatments from a fully regulated UK pharmacy with GPhC registration #9012878. This registration is publicly searchable on pharmacyregulation.org, providing transparent verification of our legitimate pharmacy status. Unlike unregulated online sellers, our Leicester-based pharmacy operates under strict MHRA oversight with complete supply chain traceability. Every prescription-only medicine we dispense undergoes rigorous quality checks and temperature-controlled storage before reaching patients.
Our regulated approach means licensed UK prescribers review every clinical assessment for both Mounjaro and Wegovy consultations. This ensures appropriate patient selection and monitoring, rather than automated prescription approval systems used by some providers. The pharmacy's established infrastructure supports both medications with identical clinical standards, giving patients confidence in treatment quality regardless of which option their prescriber recommends.
Compare Mounjaro and Wegovy Pricing: Complete UK Pharmacy Costs
EverydayMeds offers transparent pricing for both treatments when patients compare Mounjaro and Wegovy costs. Wegovy pricing starts with 0.25mg at £79.99 (weeks 1-4 starter dose), progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing convenient two-month starter supply. New customers apply code FIRST40 at checkout, whilst returning customers use code DOSE25 to access these final prices.
Mounjaro follows a different dose escalation with distinct pricing reflecting its dual-hormone mechanism. Both medications require prescription-only medicine status with identical consultation fees and delivery costs through our GPhC-registered service. Bundle options provide Reliable Supply continuity, particularly valuable during periodic shortages affecting weight management medications. The pricing reflects MHRA-approved supply chains and genuine pharmaceutical sourcing rather than grey market alternatives.
Compare Mounjaro and Wegovy: Clinical Evidence Base
Wegovy demonstrated significant efficacy in the STEP trial programme, with patients achieving approximately 15% average weight loss at 68 weeks alongside reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The STEP 5 extension showed sustained 15.2% weight reduction at two years, whilst SELECT trial data revealed 20% reduction in major cardiovascular events. These results establish Wegovy's evidence base for long-term weight management when prescribed appropriately.
Mounjaro's clinical profile stems from different trial designs and patient populations, making direct percentage comparisons inappropriate when patients compare Mounjaro and Wegovy effectiveness. Both prescription-only medicines demonstrated substantial weight reduction in their respective studies, though individual responses vary considerably. Licensed prescribers consider multiple factors including medical history, existing medications, and patient preferences when selecting between treatments.
Compare Mounjaro and Wegovy: Wegovy Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones regulating appetite and glucose metabolism. The medication binds to GLP-1 receptors in the brain's appetite centres, promoting satiety signals and reducing food cravings between meals. This mechanism slows gastric emptying, helping patients feel fuller for longer periods after eating smaller portions. Wegovy's once-weekly injection schedule maintains consistent hormone levels throughout the treatment period. The FlexTouch pen delivery system provides precise dosing with minimal injection discomfort, supporting long-term treatment adherence alongside lifestyle modifications.
Compare Mounjaro and Wegovy: EverydayMeds Ordering Process
Patients comparing Mounjaro and Wegovy through EverydayMeds complete a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Licensed UK prescribers review every consultation within standard 3 working days, with express 24-hour review available for urgent requirements. Once approved, medications ship via next-day cold-chain delivery maintaining required 2-8°C temperature throughout transport. Our Leicester pharmacy coordinates directly with patients regarding delivery scheduling and injection training resources. The regulated process ensures appropriate patient selection whilst providing convenient access to prescription-only medicines through legitimate UK healthcare pathways.
Compare Mounjaro and Wegovy: Storage and Practical Considerations
Storage requirements differ significantly when patients compare Mounjaro and Wegovy practical aspects, with Wegovy offering superior travel convenience. Wegovy maintains stability for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require 2-8°C refrigerated storage before first use, with the FlexTouch pen system providing user-friendly injection experience. Wegovy's dose escalation follows a structured 16-week progression to maintenance levels, whilst Mounjaro uses different escalation timing and maximum doses. The extended room temperature stability makes Wegovy particularly suitable for patients with frequent travel or limited refrigeration access during treatment.
Compare Mounjaro and Wegovy: GPhC Pharmacy Regulatory Compliance
EverydayMeds' GPhC registration #9012878 ensures both Mounjaro and Wegovy supply meets stringent UK pharmaceutical regulations unavailable through overseas or unlicensed providers. Our Leicester-based pharmacy undergoes regular GPhC inspections covering premises, procedures, and personnel qualifications. Licensed prescribers hold GMC registration with specialist training in obesity medicine and prescription-only medicine management. The regulated framework provides patient protection through professional indemnity, adverse event reporting, and medication quality assurance.
This regulatory compliance becomes crucial when patients compare Mounjaro and Wegovy suppliers, as both medications carry MHRA additional monitoring requirements due to their recent market authorisation. Our established pharmacy infrastructure supports comprehensive patient monitoring, drug interaction screening, and ongoing clinical support throughout treatment duration. The traceable supply chain ensures patients receive genuine medications rather than counterfeit products increasingly common in unregulated markets.
Compare Mounjaro and Wegovy: Start Your Assessment Today
EverydayMeds provides regulated access to both Mounjaro and Wegovy through our licensed prescriber network and GPhC-registered pharmacy infrastructure. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 for established pricing structure. The 3-minute clinical assessment initiates your consultation with UK-based prescribers who determine appropriate treatment selection based on individual circumstances. Our next-day delivery ensures rapid treatment initiation once prescription approval completes. Begin your weight management journey through legitimate UK healthcare channels with comprehensive ongoing support from our clinical team.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
